Lupin Diagnostics eyes 100 labs in five years

Lupin Diagnostics Ltd., a wholly owned subsidiary of Lupin Ltd., has drawn up plans to more than double the number of its laboratories and increase collection centres by threefold across the country in five years, said a top official.

“Right now, we have 36 laboratories and 600 collection centres. Our goal is to have 100 laboratories by FY28 and 2,000 collection centres in five years,” said CEO Ravindra Kumar during a press meet.

On Thursday, Mr. Kumar announced the launch of Regional Reference laboratory in Chennai. Plans are to enter tier II cities such as Coimbatore, Madurai, Tiruchiraplli and Salem and agreements have been signed with the franchisees, he said.

Regarding the expansion of laboratories, he said that each region will have at least 25 units. “Right now, we are present only in East, West and South. We will be entering North by FY27, Kerala and Gujarat soon.”

The number of collection centres will be ramped to 1,000 numbers by FY25 and 2,000 in three years.

While mentioning that 10 out of 36 laboratories have already been accredited by NABL, he said that 10 more are in the pipeline and five would get the accreditation by FY24.

Related Posts

  • Pharma
  • February 5, 2025
  • 119 views
Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

A leading pharmaceutical powerhouse renowned for innovative skincare solutions has unveiled its latest breakthrough in tackling facial hyperpigmentation. The groundbreaking serum, featuring a first-of-its-kind dual liposomal technology in India, promises…

  • Pharma
  • February 5, 2025
  • 127 views
Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners (RMPs) and representatives of pharmaceutical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

As Always Ahead of Game in healthcare, Doc was first to vote too

As Always Ahead of Game in healthcare, Doc was first to vote too

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Sun Pharma appoints Aalok Shanghvi as Chief Operating Officer

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds

Alembic Pharma Q3 results: PAT falls 23.29% amid market headwinds